Rx Data Exclusivity Should Be Removed From Trade Deal, House Dems Say
This article was originally published in The Pink Sheet Daily
Executive Summary
The Dominican Republic-Central American Free Trade Agreement provision could prevent countries from gaining access to generic drugs during a public health emergency, lawmakers say. The language would grant drug manufacturers five years of protection on data needed to gain regulatory approval.
You may also be interested in...
SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.
Roche Calls For U.S. Contract To Guarantee Tamiflu Stockpile
HHS is in discussions to purchase enough of the influenza treatment to cover a total of 3% of the U.S. population, Roche tells House hearing on pandemic preparedness. Other countries already have purchase commitments that would cover 20% to 40% of their populations.
FDA Studying Effects Of Radio-Frequency ID Technology On Liquid Drugs
The agency has seen "tremendous progress" in the move toward electronic product codes and use of radio-frequency identification, FDA says in its annual counterfeit drug update. FDA initiated 58 counterfeit drug investigations in 2004, up from 30 the previous year.